COL6A1 and colitis: NFκB signaling, in particular, plays an important role in the activation of PDGFRαhi fibroblasts during DSS colitis, as Col6a1-Cre-specific deletion of IKK2 led to reduced colitis, associated with decreased production of inflammatory mediators, reduced inflammatory cell infiltration and epithelial-specific STAT3 activation (63).